Rhythm Pharmaceuticals, Inc. (RYTM)
85.71
-2.15
(-2.45%)
USD |
NASDAQ |
Jun 10, 16:00
85.70
-0.01
(-0.01%)
After-Hours: 20:00
Rhythm Pharmaceuticals Total Liabilities (Quarterly) : 319.41M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 319.41M |
| December 31, 2025 | 342.12M |
| September 30, 2025 | 358.06M |
| June 30, 2025 | 384.64M |
| March 31, 2025 | 367.74M |
| December 31, 2024 | 371.74M |
| September 30, 2024 | 352.36M |
| June 30, 2024 | 342.50M |
| March 31, 2024 | 197.07M |
| December 31, 2023 | 162.99M |
| September 30, 2023 | 156.72M |
| June 30, 2023 | 127.66M |
| March 31, 2023 | 125.92M |
| December 31, 2022 | 118.22M |
| September 30, 2022 | 108.42M |
| June 30, 2022 | 82.05M |
| March 31, 2022 | 49.06M |
| December 31, 2021 | 45.37M |
| September 30, 2021 | 33.56M |
| June 30, 2021 | 36.70M |
| March 31, 2021 | 41.26M |
| December 31, 2020 | 20.54M |
| September 30, 2020 | 18.54M |
| June 30, 2020 | 17.73M |
| Date | Value |
|---|---|
| March 31, 2020 | 20.66M |
| December 31, 2019 | 27.50M |
| September 30, 2019 | 28.42M |
| June 30, 2019 | 29.42M |
| March 31, 2019 | 16.01M |
| December 31, 2018 | 13.95M |
| September 30, 2018 | 8.091M |
| June 30, 2018 | 7.432M |
| March 31, 2018 | 5.785M |
| December 31, 2017 | 6.948M |
| September 30, 2017 | 5.71M |
| June 30, 2017 | 5.523M |
| March 31, 2017 | 4.786M |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | 5.274M |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | 0.552M |
| September 30, 2014 | |
| June 30, 2014 | 2.439M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 357.16M |
| Biogen, Inc. | 10.83B |
| Regeneron Pharmaceuticals, Inc. | 9.445B |
| Vertex Pharmaceuticals, Inc. | 7.122B |
| AbbVie, Inc. | 143.08B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 442.32M |
| Shareholders Equity (Quarterly) | 122.91M |
| Debt to Equity Ratio | 1.847 |
| Current Ratio | 4.168 |
| Net Debt Paydown Yield | 0.10% |